Houghton, A McGarry
- Fred Hutchinson Cancer Center (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,418
- Rising Star
- Program Leader
- R01 Holder
- Long-Funded
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$3.5M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#1,418
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Houghton, A McGarry as a PI. Multi-PI records show the full award amount for context.
- 5P50CA228944-06P50Contact PIFred Hutchinson Cancer Research Center Lung SPORE$2.4Maward amount
- 1R01CA282465-01R01Contact PINeutrophil derived proteinases abolish the IFNG signature in NSCLC$573.1Kaward amount
- 5R01CA243328-05R01Contact PITumor-specific autoantibodies for SCLC early detection$431.8Kaward amount
Award organization
Organizations that administered FY2023 awards listing Houghton, A McGarry as a PI.
FY2023 award administered by Fred Hutchinson Cancer Center (WA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardFred Hutchinson Cancer Center
- 2009$500K Cumulative Funding
- 2011$1M Cumulative Funding
- 2011R01 Grant Holder
- 2015$2M Cumulative Funding
- 2015Entered Top 50% NationallyRanked #8462
- 2015Program/Center Grant Leader
- 2019$5M Cumulative Funding
- 2019Entered Top 25% NationallyRanked #1321
- 2019Entered Top 10% NationallyRanked #1321
- 2021$10M Cumulative Funding